Allarity Therapeutics (ALLR) Notes Payables (2020 - 2026)
Allarity Therapeutics' (ALLR) quarterly Notes Payables came in at $1.4 million in Q1 2026, up 3.89% YoY from $1.4 million in Q1 2025, and up 1.14% on a QoQ basis from $1.4 million in Q4 2025.
Allarity Therapeutics (ALLR) Notes Payables (2020 - 2026) Analysis & Trends
Allarity Therapeutics (ALLR) has 7 years of Notes Payables data on file, last reported at $1.4 million in Q1 2026.
- Quarterly Notes Payables rose 3.89% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 million (up 3.89% YoY) and the FY2025 annual result came in at $1.4 million, up 139900.0% from the prior year.
- Notes Payables improved to $1.4 million in Q1 2026, from $1.4 million in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $3.9 million in Q3 2023 to a low of $1000.0 in Q4 2024.
- A 5-year average of $1.7 million and a median of $1.4 million in 2025 frame the typical range for Notes Payables.
- Annual changes were most pronounced in 2024 — Notes Payables slumped 99.95% — and 2025, when it jumped 139900.0%.
- Tracing ALLR's Notes Payables over 5 years: stood at $374000.0 in 2022, then soared by 247.59% to $1.3 million in 2023, then plunged by 99.92% to $1000.0 in 2024, then jumped by 139900.0% to $1.4 million in 2025, then grew by 1.14% to $1.4 million in 2026.
- The last three Notes Payables figures came in at $1.4 million (Q1 2026), $1.4 million (Q4 2025), and $1.4 million (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Allarity Therapeutics | 23.23 Mn | 23.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.42 Mn |
| Dec 31, 2025 | 1.40 Mn |
| Mar 31, 2025 | 1.36 Mn |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 1.33 Mn |
| Mar 31, 2024 | 2.66 Mn |
| Dec 31, 2023 | 1.30 Mn |
| Sep 30, 2023 | 3.95 Mn |
| Jun 30, 2023 | 1.14 Mn |
| Dec 31, 2022 | 374,000.00 |
| Sep 30, 2022 | 2.80 Mn |
| Jun 30, 2022 | 2.88 Mn |
| Mar 31, 2022 | 3.17 Mn |
| Dec 31, 2021 | 11.27 Mn |
| Sep 30, 2021 | 218,000.00 |
| Dec 31, 2020 | 47,000.00 |